China Everbright Ltd (165):企業の財務・戦略的SWOT分析

◆英語タイトル:China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDFS28231FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

China Everbright Ltd (165) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China Everbright Ltd (China Everbright), a subsidiary of China Everbright Group Ltd, is a diversified provider of financial services. Its portfolio of services consists of direct investment, asset management, investment banking, mezzanine funds, back-end hedge funds, bond investment funds, asset investment, and brokerage and wealth management to high-net worth individual and institutional clients. The company offers these investments to its customers through hedge funds, venture capital funds, and private equity funds in unlisted companies in China and abroad. It has an operational presence in Hong Kong and Mainland China. China Everbright is headquartered in Hong Kong City, Hong Kong Republic of China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
China Everbright Ltd – Key Facts
China Everbright Ltd – Key Employees
China Everbright Ltd – Key Employee Biographies
China Everbright Ltd – Major Products and Services
China Everbright Ltd – History
China Everbright Ltd – Company Statement
China Everbright Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
China Everbright Ltd – Business Description
Business Segment: Fund Management
Overview
Performance
Key Stats
Business Segment: Principal Investment
Overview
Performance
Key Stats
Geographical Segment: Hong Kong
Performance
Geographical Segment: Mainland China
Performance
China Everbright Ltd – SWOT Analysis
SWOT Analysis – Overview
China Everbright Ltd – Strengths
China Everbright Ltd – Weaknesses
China Everbright Ltd – Opportunities
China Everbright Ltd – Threats
China Everbright Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
China Everbright Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
China Everbright Ltd, Key Facts
China Everbright Ltd, Key Employees
China Everbright Ltd, Key Employee Biographies
China Everbright Ltd, Major Products and Services
China Everbright Ltd, History
China Everbright Ltd, Other Locations
China Everbright Ltd, Subsidiaries
China Everbright Ltd, Key Competitors
China Everbright Ltd, Ratios based on current share price
China Everbright Ltd, Annual Ratios
China Everbright Ltd, Annual Ratios (Cont...1)
China Everbright Ltd, Interim Ratios
China Everbright Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[China Everbright Ltd (165):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Nilkamal Ltd:企業の戦略・SWOT・財務情報
    Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report Summary Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Aker Solutions ASA (AKSO):企業の財務・戦略的SWOT分析
    Aker Solutions ASA (AKSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Britvic Plc:戦略・SWOT・企業財務分析
    Britvic Plc - Strategy, SWOT and Corporate Finance Report Summary Britvic Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Jack Henry & Associates, Inc.:企業の戦略・SWOT・財務分析
    Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Commercial Bank Of Ceylon Plc:企業の戦略・SWOT・財務分析
    Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析
    Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Kasbah Resources Limited:戦略・SWOT・企業財務分析
    Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • Shenergy Co., Ltd. (600642):電力:M&Aディール及び事業提携情報
    Summary Shenergy Company, Ltd. (Shenergy) is China-based gas and electricity company. The company is engaged in the construction, investment, operations and management of petroleum, natural gas and electric power. Its electricity projects include hydropower, coal-fired power and thermal power genera …
  • PharmaCyte Biotech Inc (PMCB):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …
  • Solco Biomedical Co Ltd (043100)-医療機器分野:企業M&A・提携分析
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. It offers implants, instruments and health care products. So …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lisega SE:企業の戦略的SWOT分析
    Lisega SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Microchip Technology Inc (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Inc (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Royal Bank of Scotland Group Plc:企業の戦略・SWOT・財務情報
    The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆